Matthew Calistri | Vice President of Investor Relations |
Tony Coles | Chairperson & Chief Executive Officer |
Ray Sanchez | Chief Medical Officer |
John Renger | Chief Scientific Officer |
Mark Bodenrader | Interim Chief Financial Officer |
Michael Yee | Jefferies |
Matthew Harrison | Morgan Stanley |
Paul Matteis | Stifel |
Douglas Tsao | H.C. Wainwright |
Omari Baruti | Goldman Sachs |
Tiffany Sun | JPMorgan |
Good morning. Welcome to the Cerevel Therapeutics Fourth Quarter and Full Year 2021 Financial Results Conference Call. At this time, all participants are in a listen-only mode. Later, you will have the opportunity to ask questions during the Q&A portion of the call. Please note that this call maybe recorded.